Actos Now for Prevention of Diabetes (ACT NOW)
Phase of Trial: Phase III
Latest Information Update: 16 Sep 2016
At a glance
- Drugs Pioglitazone (Primary)
- Indications Glucose intolerance; Type 2 diabetes mellitus
- Focus Biomarker; Registrational; Therapeutic Use
- Acronyms ACT-NOW
- 16 Sep 2016 Results assessing the effect of pioglitazone on Fibroblast Growth Factor-21 (FGF-21), presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes.
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association (n = 531).
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History